Podcast


Presenter: Dr. Michael Allan James McCormack BSc (Pharm) Pharm D

In episode 480, James and Mike talk about two recent meta-analyses that have done a solid job of looking at the impact of lowering blood pressure and using SGLT-2s and GLP-1s to reduce risk. Both publications lend credence to the concept of focusing much more on risk reduction goals than blood pressure or glucose thresholds….

This content is for *CFPC Member Rate, CFPC Member Rate, Non-CFPC Member Rate, and Resident members only.
Login Join Now



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

In the Clinic Episode #21: Low Back Pain

Mike, Jessica and Jennifer present the case of Guy Lumbago, a 40 year old man with low back pain. Tune in as the team discusses the diagnosis and management of…
Listen 0.5 credits available

In the Clinic Episode #20: Bronchiolitis

Mike, Jess and Jennifer discuss the case of Aira Salter, a 16 month old who is brought to the office with coughing and wheezing.
Listen 0.5 credits available

In the Clinic Episode #19: Alcohol use disorder

In this episode, Mike, Jess and Émélie discuss Mr. Dion Silenus, a 60 year old man whose concern is that his heart is acting up. tune in to find out…
Listen 0.5 credits available

Presenter(s):

Dr. Michael Allan James McCormack BSc (Pharm) Pharm D

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr. Michael Allan
  • James McCormack BSc (Pharm) Pharm D

Spearkers do not have any conflicts of interest to declare.